相关实验视频

Updated: Jun 3, 2025

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis

Published on: March 30, 2019

阿托瓦斯塔丁在血液恶性瘤中对瘤性miRNA的影响:一项中心研究

Jood Hashem¹, Farah Alsukhni¹, Hassan Abushukair²

¹Department of Medical Laboratory Sciences, Jordan University of Science and Technology, Irbid 22110, Jordan.

|January 8, 2025

概括

阿托瓦斯塔丁治疗改变了血液恶性瘤中的微RNA (miRNA) 表达,确定了改善患者存活的潜在生物标志物. 这项研究强调了他类药物.

科学领域:

在瘤学瘤学.
药理学药理学是指药理学的学科.
分子生物学分子生物学

背景情况:

众所周知降低胆固醇的他类药物在固体瘤中显示出抗癌潜力,但在血液性恶性瘤 (HM) 中未得到充分研究.
微RNA (miRNA) 在癌症的发展和进展中起着至关重要的作用,使它们成为潜在的治疗点和生物标志物.

研究的目的:

为了研究阿托瓦斯塔丁对血液恶性瘤患者miRNA表达的作用.
为了确定不同表达的miRNA和由阿托瓦斯塔丁治疗影响的相关调节途径.
探索特定miRNA表达水平与HM患者的整体存活率之间的相关性.

主要方法:

在12名HM患者的血循环miRNAs使用qPCR量化,在6周的阿托瓦斯塔丁疗程之前和之后进行量化.
不同表达分析确定了显著的miRNAs (折叠变化>2或<0.5,p<0.05).
用DAVID 6.8.8对目标基因进行了基因本体学 (GO) 和KEGG通路丰富分析.

主要成果:

在95个miRNA中,有14个在atorvastatin治疗后显示出显著的表达变化,包括瘤抑制剂的上调,如miR-198,miR-29a+b+c和let-7家族,以及miR-150的下调.
在白血病和淋巴瘤队列中,miR-222,miR-194,miR-128b和miR-199b的更高表达与更好的整体存活率相关.
丰富分析显示,阿托瓦斯塔丁对PI3k-Akt和上皮-介质酶过渡等途径的影响.

结论:

阿托瓦斯塔丁可调节HM患者的miRNA表达,上调瘤抑制剂并影响关键瘤性途径.
特定的miRNAs (miR-222,miR-194,miR-128b,miR-199b) 可能作为预后生物标志物用于改善HM的生存.
研究结果支持个性化治疗策略,通过准他类药物调节的途径来改善患者的治疗结果.

关键词:

血液学的恶性瘤.这种白血病是白血病.淋巴瘤淋巴瘤是什么这是一个微型RNA.斯塔丁斯塔丁斯是一个国家.

更多相关视频

An In Vitro Protocol for Evaluating MicroRNA Levels, Functions, and Associated Target Genes in Tumor Cells

An In Vitro Protocol for Evaluating MicroRNA Levels, Functions, and Associated Target Genes in Tumor Cells

Published on: May 21, 2019

In Vivo Inhibition of MicroRNA to Decrease Tumor Growth in Mice

In Vivo Inhibition of MicroRNA to Decrease Tumor Growth in Mice

Published on: August 23, 2019

相关概念视频

MicroRNAs

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...

Cancer Therapies

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...

Drugs that Stabilize Microtubules

Drugs that Stabilize Microtubules

Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...